Chromadex Corp
ChromaDex Corporation operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) t… Read more
Chromadex Corp (CDXC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: 0.186x
Based on the latest financial reports, Chromadex Corp (CDXC) has a cash flow conversion efficiency ratio of 0.186x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($8.58 Million) by net assets ($46.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Chromadex Corp - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Chromadex Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Chromadex Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chromadex Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pansoft Company Limited
SHE:300996
|
N/A |
|
Yan Tai Shuang Ta Food Co Ltd
SHE:002481
|
0.126x |
|
PSG Corp. PCL
BK:PSG
|
0.029x |
|
Sino BiologicalInc.
SHE:301047
|
N/A |
|
Compass Diversified Holdings
NYSE:CODI
|
0.082x |
|
Major Drilling Group International Inc
PINK:MJDLF
|
0.037x |
|
Nanjing Canatal Data Centre Environmental Tech Co Ltd Class A
SHG:603912
|
-0.015x |
|
Columbus McKinnon Corporation
NASDAQ:CMCO
|
0.022x |
Annual Cash Flow Conversion Efficiency for Chromadex Corp (2007–2024)
The table below shows the annual cash flow conversion efficiency of Chromadex Corp from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $46.09 Million | $12.11 Million | 0.263x | +5.04% |
| 2023-12-31 | $28.46 Million | $7.12 Million | 0.250x | +147.50% |
| 2022-12-31 | $28.67 Million | $-15.10 Million | -0.527x | +30.86% |
| 2021-12-31 | $31.73 Million | $-24.16 Million | -0.762x | -18.00% |
| 2020-12-31 | $16.42 Million | $-10.60 Million | -0.645x | +35.44% |
| 2019-12-31 | $20.45 Million | $-20.44 Million | -1.000x | -29.95% |
| 2018-12-31 | $27.18 Million | $-20.91 Million | -0.769x | -322.41% |
| 2017-12-31 | $53.83 Million | $-9.80 Million | -0.182x | +38.14% |
| 2016-12-31 | $9.97 Million | $-2.94 Million | -0.294x | +26.44% |
| 2015-12-31 | $5.27 Million | $-2.11 Million | -0.400x | +37.98% |
| 2014-12-31 | $4.00 Million | $-2.58 Million | -0.645x | +6.39% |
| 2013-12-31 | $5.67 Million | $-3.91 Million | -0.689x | +72.79% |
| 2012-12-31 | $3.99 Million | $-10.12 Million | -2.534x | -58.35% |
| 2011-12-31 | $2.56 Million | $-4.10 Million | -1.600x | -196.80% |
| 2010-12-31 | $4.94 Million | $-2.66 Million | -0.539x | -42.56% |
| 2009-12-31 | $1.05 Million | $-396.17K | -0.378x | +65.57% |
| 2008-12-31 | $1.75 Million | $-1.92 Million | -1.098x | +99.49% |
| 2007-12-31 | $180.00 | $-38.48K | -213.794x | -- |